Pande Vijay Satyanand bought BIOA
August 7, 2025 · Form 4 insider transaction
Pande Vijay Satyanand bought 22,000 shares of BioAge Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,000
Price
$0.00
Total value
N/A
InsiderPande Vijay Satyanand
RoleDirector
CompanyBioAge Labs, Inc. (BIOA)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 7, 2025
Filing dateAugust 11, 2025
Shares owned after22,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.